LANZILLOTTA, MARCO
 Distribuzione geografica
Continente #
EU - Europa 644
NA - Nord America 347
AS - Asia 74
OC - Oceania 4
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.072
Nazione #
US - Stati Uniti d'America 343
IT - Italia 324
SE - Svezia 236
CN - Cina 38
FI - Finlandia 30
IN - India 16
DE - Germania 15
GB - Regno Unito 12
IE - Irlanda 10
CA - Canada 4
HK - Hong Kong 4
PH - Filippine 4
IL - Israele 3
PK - Pakistan 3
RU - Federazione Russa 3
UA - Ucraina 3
AL - Albania 2
AU - Australia 2
CH - Svizzera 2
GR - Grecia 2
IR - Iran 2
JP - Giappone 2
NL - Olanda 2
NZ - Nuova Zelanda 2
TN - Tunisia 2
CZ - Repubblica Ceca 1
EU - Europa 1
FR - Francia 1
KR - Corea 1
RO - Romania 1
SG - Singapore 1
Totale 1.072
Città #
Lawrence 69
Princeton 69
New York 46
Shanghai 38
Milan 36
Helsinki 29
Ashburn 28
Rome 19
Pune 15
Seattle 13
Turin 11
Rovigo 10
Cagliari 9
Dublin 9
Galliate 9
London 9
Vaprio d'Adda 8
Verona 8
Bari 7
Naples 6
Bergamo 5
Mezzolombardo 5
Mira 5
Vittoria 5
Alessandria 4
Borås 4
Genoa 4
Minerbio 4
Quezon City 4
Trino 4
Angera 3
Gallarate 3
Kyiv 3
Los Angeles 3
Padova 3
Piana degli Albanesi 3
Salt Lake City 3
San Lazzaro di Savena 3
Vimercate 3
Ancona 2
Andover 2
Athens 2
Atlanta 2
Bacoli 2
Benken 2
Bologna 2
Calci 2
Campobasso 2
Casoria 2
Castel Madama 2
Cosenza 2
Feilding 2
Florence 2
Frankfurt am Main 2
Hong Kong 2
Islamabad 2
Lenta 2
Mantova 2
Melbourne 2
Messina 2
Parabiago 2
Pedrengo 2
Pescara 2
Portogruaro 2
Ravenna 2
Reggio Emilia 2
Rimini 2
Rozzano 2
Secaucus 2
Segrate 2
Sessa Aurunca 2
Tel Aviv 2
Tirana 2
Toronto 2
Torre Del Greco 2
Trieste 2
Venice 2
Vero Beach 2
Aachen 1
Aci Catena 1
Amsterdam 1
Beaverton 1
Birmingham 1
Bolzano 1
Brighton 1
Buk-gu 1
Cambridge 1
Cedar Crest 1
Central 1
Civitavecchia 1
Conshohocken 1
Cork 1
Esslingen am Neckar 1
Falkenstein 1
Fort Lauderdale 1
Hanover 1
Lahore 1
Lainate 1
Moscow 1
Mountain View 1
Totale 619
Nome #
PACHIMENINGITE IPERTROFICA IGG4-CORRELATA: DIAGNOSI E RISPOSTA TERAPEUTICA 168
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 41
Dupilumab as a potential steroid-sparing treatment for IgG4-related disease. 33
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 30
A subset of CD4+CD8α- Cytotoxic T cells is expanded in patients with IgG4-Related type 1 autoimmune pancreatitis and decreases with glucocorticoid treatment 29
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 25
IMMUNOTERAPIA SPECIFICA E MALATTIA IgG4-CORRELATA: STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO 25
IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients 24
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 23
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: An open-label cohort study 22
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase 22
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 22
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 22
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 21
A cd8 alpha-negative subset of cd4+slamf7+ cytotoxic t cells is expanded in patients with igg4-related disease and decreases following glucocorticoid treatment 20
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease 19
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease 18
A unique case of IgG4-related pachymeningitis treated with intrathecal rituximab 18
A CD8α− Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment 17
Urgent manifestations of immunoglobulin G4-related disease 17
Methotrexate as induction of remission therapy for localized manifestations of IgG4-Related Disease. 17
B LYMPHOCYTES DIRECTLY CONTRIBUTE TO TISSUE FIBROSIS IN IGG4-RELATED DISEASE 16
B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease. 16
Advances in the diagnosis and management of IgG4 related disease. 16
B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma 15
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes 14
EFFETTI DEL PREDNISONE SULLE SOTTOPOPOLAZIONI B LINFOCITARIE NEI PAZIENTI CON MALATTIA IgG4-CORRELATA 14
Persistence of circulating T-follicular helper cells after rituximab is associated with relapse of IgG4-related disease 14
CLINICAL PHENOTYPES OF IGG4- RELATED DISEASE REFLECT DIFFERENCES IN EPIDEMIOLOGICAL FEATURES, SEROLOGICAL FINDINGS,AND PROGNOSTIC OUTCOMES 14
Deconstructing IgG4-related disease involvement of midline structures: Comparison to common mimickers. 13
Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease 13
Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: A case report and review of the literature. 13
IDENTIFICAZIONE DI UNA SOTTOPOPOLAZIONE CD8- DI LINFOCITI CD4 CITOTOSSICI ESPANSA NEI PAZIENTI CON MALATTIA IGG4-CORRELATA E RESPONSIVA ALLA TERAPIA CON GLUCOCORTICOIDI 13
Incidence of endocrine and exocrine insufficiency in patients with autoimmune pancreatitis at diagnosis and after treatment: a systematic review and meta-analysis 12
IGG4 RELATED HYPERTROPHIC PACHYMENINGITIS: DIAGNOSTIC APPROACH AND THERAPEUTIC OUTCOMES 12
INFLAMMATORY ACTIVITY OF IgG4-RELATED DISEASE LESIONS ASSESSED BY QUANTITATIVE POSITRON EMISSION TOMOGRAPHY CORRELATES WITH CIRCULATING PLASMABLASTS LEVELS 12
METHOTREXATE AS INDUCTION OF REMISSION THERAPY FOR LOCALIZED MANIFESTATIONS OF IGG4-RELATED DISEASE 12
IGG4 RELATED HYPERTROPHIC PACHYMENINGITIS: DIAGNOSTIC APPROACH AND THERAPEUTIC OUTCOMES 12
Intrathecal rituximab for IgG4-related hypertrophic pachymeningitis 11
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circula-ting plasmablasts in IgG4-related type 1 au-toimmune pancreatitis and other organs 11
LONG-TERM EFFICACY OF RITUXIMAB MAINTENANCE THERAPY FOR IGG4- RELATED DISEASE RITUXIMAB MAINTENANCE THERAPY IN IGG4-RELATED DISEASE 11
INCREASE OF CIRCULATING MEMORY B CELLS AFTER GLUCOCORTICOID-INDUCED REMISSION PREDICTS IGG4-RELATED DISEASE RELAPSE 11
Mer tyrosine kinase as a possible link between resolution of inflammation and tissue fibrosis in IgG4-related disease 11
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation 10
EFFICACY AND SAFETY OF RITUXIMAB FOR INDUCTION OF REMISSION AND MAINTENANCE OF IGG4-RELATED DISEASE: EXPERIENCE FROM AN ITALIAN NATIONAL REFERRAL CENTRE 10
MALATTIA IGG4-CORRELATA: ESPERIENZA QUINQUENNALE MONOCENTRICA SU UNA CORTE ITALIANA DI 150 PAZIENTI (2013 - 2018) 10
EFFETTI DELLA TERAPIA CON PREDNISONE E METHOTREXATE SULLE SOTTOPOPOLAZIONI B LINFOCITARIE NEI PAZIENTI AFFETTI DA MALATTIA-IgG4 CORRELATA 10
ASSOCIAZIONE TRA MALATTIA IGG4-CORRELATA E IMMUNOTERAPIA ALLERGENE-SPECIFICA. STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO. 9
EFFECTS OF COMBINED THERAPY WITH PREDNISONE AND METHOTREXATE ON B CELL SUBPOPULATIONS IN PATIENTS WITH IGG4-RELATED DISEASE 9
CLINICAL MANIFESTATIONS OF IGG4-RELATED DISEASE ONSET REQUIRE ADMISSION TO THE EMERGENCY DEPARTMENT IN THE MAJORITY OF CASES. EXPERIENCE FROM A SINGLE ITALIAN REFERRAL CENTRE 9
Effects Of Glucocorticoids On B Cell Subpopulations In Patients With IgG4-Related type I autoimmune pancreatitis 9
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19 9
Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease 8
Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: A European multi-centre study 8
Differential EUS findings in focal type 1 autoimmune pancreatitis and pancreatic cancer: A proof-of-concept study 8
Methotrexate as Induction of Remission Therapy for Type 1 Autoimmune Pancreatitis 8
CLINICAL PHENOTYPES OF IGG4-RELATED DISEASE REFLECT DIFFERENCES IN EPIDEMIOLOGICAL, IMMUNOLOGICAL AND PROGNOSTIC FEATURES 8
MERTK AND THE RESOLUTION OF INFLAMMATION IN IGG4-RELATED DISEASE 8
Role of systemic immunosuppression on subglottic stenosis in granulomatosis with polyangiitis: Analysis of a single-centre cohort 7
Igg4-related disease of the oral cavity. Case series from a large single-center cohort of italian patients 7
EFFECTS OF GLUCOCORTICOIDS AND METHOTREXATE-BASED THERAPEUTIC REGIMENS ON B CELL SUBPOPULATIONS IN PATIENTS WITH IGG4-RELATED DISEASE 7
CIRCULATING PLASMABLASTS LEVELS REFLECT INFLAMMATORY ACTIVITY IN IGG4-RELATED DISEASE LESIONS AS ASSESSED BY QUANTITATIVE POSITRON EMISSION TOMOGRAPHY 7
METHOTREXATE AS INDUCTION OF REMISSION THERAPY FOR LOCALIZED MANIFESTATIONS OF IGG4-RELATED DISEASE 7
Immunology of IgG4-related disease 6
Methotrexate as induction of remission the-rapy for IgG4-Related type 1 Autoimmune Pancreatitis 6
FENOTIPI CLINICI DELLA MALATTIA IGG4 CORRELATA: ANALISI CROSS-SECTIONAL DI UNA CORTE INTERNAZIONALE 6
The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. 6
An International, Multi-Specialty Validation Study of the IgG4-Related Disease Responder Index 6
Serum IgG4 level predicts COVID-19 related mortality 5
Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse 5
EFFECTS OF COMBINED THERAPY WITH PREDNISONE AND METHOTREXATE ON B CELL SUBPOPULATIONS IN PATIENTS WITH IGG4-RELATED DISEASE 5
IGG4-RELATED DISEASE IN ITALY: RESULTS FROM A MONOCENTRIC COHORT OF 150 PATIENTS (2013–2018) 5
DECONSTRUCTING LA MALATTIA DA IGG4 CON INTERESSAMENTO DELLE STRUTTURE MEDIANE: CONFRONTO CON I COMUNI “MIMICKERS” 5
IgG4-RELATED DISEASE PRESENTATION REQUIRES ADMISSION TO THE EMERGENCY DEPARTMENT IN THE MAJORITY OF CASES 5
Serum IgG4 elevation in hyper-inflamed COVID-19 patients. Author's reply 4
EFFICACIA E SICUREZZA DELLA SOMMINISTRAZIONE INTRATECALE DI RITUXIMAB PER IgG4-RELATED PACHIMENINGITE IPERTROFICA REFRATTARIA 4
Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: A systematic review and meta-analysis 3
Effects of glucocorticoids on B-cell subpopulations in patients with IgG4-related disease 3
Roles of Plasmablasts and B Cells in IgG4-Related Disease: Implications for Therapy and Early Treatment Outcomes 3
The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. 3
HLA-DRB1∗16 and -DQB1∗05 alleles are strongly associated with autoimmune pancreatitis in a cohort of hundred patients 3
Association of IgG4-related disease and systemic rheumatic disorders 1
Totale 1.171
Categoria #
all - tutte 13.347
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.347


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208 1 0 0 0 0 0 7 0 0 0 0 0
2020/202121 1 0 1 4 1 8 0 1 1 1 2 1
2021/2022156 0 0 46 12 2 10 7 9 21 15 18 16
2022/2023546 170 93 42 6 12 54 53 40 33 5 12 26
2023/2024435 26 39 69 46 38 88 22 69 6 24 8 0
Totale 1.171